Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Placebo-controlled Double Blind Comparative Study to Investigate the Efficacy and Safety of DA-9501 in Sedation During the Surgery With Epidural Anesthesia or Spinal Anesthesia Without Intubation Under Monitored Sedation Care

NCT01438957 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01438957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01438957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Placebo-controlled Double Blind Comparative Study to Investigate the Efficacy and Safety of DA-9501 in Sedation During the Surgery With Epidural Anesthesia or Spinal Anesthesia Without Intubation Under Monitored Sedation Care
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
June 3, 2011
Completion date
November 18, 2011
Enrollment
119 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

sedation